| Issue |
Title |
| Vol 62, No 1 (2013) |
To what classification of gestosis (preeclampsia) should adhere a doctor in daily work? |
|
|
Savelyeva G.M., Krasnopolskiy V.I., Strizhakov A.N., Radzinskiy V.Y., Shalina R.I., Kurtser M.A. |
| "... The present-day designation of gestosis as preeclampsia and eclampsia excludes the notion of “pre ..." |
| Vol 66, No 4 (2017) |
Compared diagnostic value of proteinuria definition applying different methods at pregnants with preeclampsia |
|
|
Mozgovaya E.V., Androsova N.E., Dorofeicov V.V. |
| "... significance of proteinuria estimation by different methods at pregnants with preeclampsia, conducted ..." |
| Vol 66, No 6 (2017) |
The content of matrix metalloproteinase-12 in pregnancy complicated by preeclampsia |
|
|
Yakovleva N.Y., Vasileva E.Y., Kuznetsova L.V., Shelepova E.S., Khazova E.L., Repinskaya E.A. |
| "... (MMP-12) in pregnancy complicated and not complicated by preeclampsia.
Materials and methods ..." |
| Vol 61, No 5 (2012) |
The usual Comment to clinical Protocol “Hypertension during pregnancy, preeclampsia, eclampsia” |
|
|
Aylamazyan E.K., Repina M.A. |
| "... (Washington, DC,2000) [6]; 3 centres Collaboration Consensus Guideline-Hypertension in pregnancy, Preeclampsia ..." |
| Vol 61, No 5 (2012) |
Secretory placental factors influence to endothelial cells EA.hy926 proliferation |
|
|
Stepanova O.I., Furayeva K.N., Nikolayenkov I.P., Selkov S.A., Sokolov D.I. |
| Vol 64, No 1 (2015) |
Systemic Enzyme Therapy during expectant management of preeclampsia: controlled randomised trial |
|
|
Repina M.A., Korzo T.M. |
| "... women with mild preeclampsia. Outcome for mothers and fetus, mechanism of action discussed. ..." |
| Vol 65, No 2 (2016) |
Pre-eclampsia. Selection of obstetric tactics |
|
|
Dobrokhotova Y.E., Makarov O.V., Lysyuk E.Y., Olenev A.S., Kouznetsov P.A., Djokhadze L.S., Osmanova A.P. |
| "... examined: I group - 50 pregnant women with preeclampsia moderate; II group - 36 pregnant women ..." |
| Vol 67, No 6 (2018) |
Thrombodynamic method of evaluation of some hemostatic parametersin healthy pregnant women and in women with preeclampsia |
|
|
Kuznik B.I., Zagorodnyaya E.D., Iozefson S.A., Isakova N.V. |
| "... is inhibited. These changes are particularly pronounced in pregnancy complicated by preeclampsia. The existing ..." |
| Vol 64, No 5 (2015) |
Severe obstetric complications as a manifestation of thrombotic microangiopathy |
|
|
Makatsaria A.D., Akinshina S.V., Bitsadze V.O., Andreeva M.D. |
| "... , including severe preeclampsia, premature detachment of normally situated placenta, septic shock. ..." |
| Vol 65, No 5 (2016) |
Obesity and ovarian insufficiency |
|
|
Misharina E.V., Abashova E.I., Potin V.V. |
| "... ; ovarian insufficiency; aromataza; gestational diabetes mellitus; hypertension; preeclampsia; macrosomia ..." |
| Vol 66, No 3 (2017) |
Peculiarities of placental microRNA expression in pregnancies complicated by gestational diabetes mellitus and preeclampsia |
|
|
Pakin V.S., Vashukova E.S., Kapustin R.V., Arzhanova O.N., Glotov A.S., Baranov V.S. |
| "... PLACENTAL MICRORNA EXPRESSION IN PREGNANCIES
COMPLICATED BY GESTATIONAL DIABETES MELLITUS AND PREECLAMPSIA ..." |
| Vol 67, No 2 (2018) |
Systematization of obstetric bleeding and preeclampsia “near-missˮ opportunity reasons |
|
|
Davlyatova G.K., Kamilova M.Y., Ishan-Khodzhaeva F.R. |
| "... The results of the systematization of reasons for obstetric bleeding and preeclampsia near-miss ..." |
| Vol 65, No 6 (2016) |
The СYP24A gene expression the placental tissue during pregnancy |
|
|
Shelepova E.S., Freylikhman O.A., Riabokon N.R., Zhebrun D.A., Kostareva A.A., Zazerskaya I.E. |
| "... with different saturation of the body with vitamin D during normal pregnancy and preeclampsia.
Materials ..." |
| Vol 64, No 4 (2015) |
The results of the use of new criteria for the diagnosis and treatment of gestational diabetes mellitus |
|
|
Borovik N.V., Tiselko A.V., Arzhanova O.N., Kapustin R.V., Potin V.V., Androsova N.E. |
| "... test; glucose; preeclampsia; cesarean section; macrosomia; hypoglycemia of
newborn; insulin therapy ..." |
| Vol 64, No 3 (2015) |
Identification of gestosis (preeclampsia) risk and evaluation of efficiency of its prevention by means of noninvasive measurement of endothelial function |
|
|
Mozgovaya E.V., Postnikova T.B., Arzhanova O.N., Repinskaya E.A., Serdyukov S.V., Vinokurova N.V. |
| "... factors of preeclampsia and with revealed endothelial dysfunction by means of the device EndoPat-2000 ..." |
| Vol 64, No 2 (2015) |
Clinical value of determination of markers of a thrombophylia at patients with the complicated pregnancy in the anamnesis |
|
|
Andreeva M.D. |
| "... The results of the survey of 214 patients with the complicated pregnancy (a preeclampsia ..." |
| Vol 62, No 2 (2013) |
Diabetic microvascular complications(retinopathy and nephropathy) and pregnancy |
|
|
Borovik N.V., Potin V.V., Rutenburg Y.L. |
| "... mellitus; diabetic retinopathy;
diabetic nephropathy; preeclampsia.
■ Адреса авторов для переписки ..." |
| Vol 66, No 3 (2017) |
Causes of patients’ obstetric complications after ART |
|
|
Arzhanova O.N., Paikacheva Y.M., Ruleva A.V., Kapustin R.V., Nichiporuk N.G. |
| "... of pregnant women: group I – 86 patients with placental insufficiency and preeclampsia, group II – 81 women ..." |
| Vol 67, No 3 (2018) |
Possibilities for prediction and prevention of preeclampsia in women with diabetes mellitus |
|
|
Kapustin R.V. |
| "... doses of acetylsalicylic acid for preventing preeclampsia in diabetic pregnancy. In addition ..." |
| Vol 67, No 4 (2018) |
Сystatin C potential use in the diagnosis of various diseases |
|
|
Glavnova O.B., Yarmolinskaya M.I., Suslova S.V., Borovik N.V. |
| "... of preeclampsia. ..." |
| Vol 63, No 6 (2014) |
Endothelial dysfunction in pathogenesis of preeclampsia |
|
|
Makulova M.V. |
| "... Preeclampsia is a severe complication of 2-25 % of pregnancies. Causes and mechanisms ..." |
| 1 - 21 of 21 Items |
|
